Stability of valganciclovir in extemporaneously compounded liquid formulations

American Journal of Health-System Pharmacy

Volumn 60, Issue 7, 2003, Pages 687-690

  Henkin, Carolyn C ^a   Griener, James C ^b   Ten Eick, Andrew P ^c  

^a CHILDREN S MEDICAL CENTER   (United States)

^b School of Pharmacy   (United States)

^c Children's Medical Center of Dallas ^*

Author keywords

[No Author keywords available]

Indexed keywords

DRUG VEHICLE; GANCICLOVIR; ORA PLUS; ORA SWEET; UNCLASSIFIED DRUG; VALGANCICLOVIR; WATER;

ARTICLE; COLOR; CYTOMEGALOVIRUS INFECTION; DIASTEREOISOMER; DRUG DEGRADATION; DRUG FORMULATION; DRUG STABILITY; DRUG STORAGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID; PH; PRIORITY JOURNAL; SUSPENSION; SYRUP;

EID: 0037528868     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/60.7.687     Document Type: Article

References (10)

1. McGavin JK, Goa KL. Ganciclovir: an update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients. Drugs. 2001; 61: 1153-83.
2. Singh N. The current management of infectious diseases in the liver transplant recipient. Clin Liver Dis. 2000; 4: 657-73.
3. Van der Bij W, Speich R. Management of cytomegalovirus infection and disease after solid-organ transplantation. Clin Infect Dis. 2001; 33(suppl 1):S32-7.
4. Cytovene (ganciclovir) package insert. Nutley, NJ: Roche Laboratories; 2000 Sep.
5. Food and Drug Administration. Drug approvals for March 2001. www.fda.gov/ cder/da/da0301.htm (accessed 2002 May 25).
6. Brown F, Banken L, Saywell K et al. Pharmacokinetics of valganciclovir and ganciclovir following multiple oral dosages of valganciclovir in HIV- and CMV-seropositive volunteers. Clin Pharmacokinet. 1999; 37:167-76.
7. Pescovitz MD, Rabkin J, Merion RM et al. Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients. Antimicrob Agents Chemother. 2000; 10:2811-5.
8. Valcyte (valganciclovir) package insert. Nutley, NJ: Roche Laboratories; 2001 Mar.
9. Anaizi NH, Dentinger PJ, Swenson CF. Stability of valganciclovir in an extemporaneously compounded oral liquid. Am J Health-Syst Pharm. 2002; 59: 1267-70.
10. Chan R, LaFargue J, Reeve RL et al. An HPLC method for the determination of diastereomeric prodrug RS-79070-004 in human plasma. J Pharm Biomed Anal. 1999; 21:647-56.